261Y000207 - MEDICAMENTS IN THE ONCOLOGY AND IMMUNOMODULATOR FIELD

This tender, referenced as 261Y000207, concerns the procurement of 'Medicaments in the Oncology and Immunomodulator Field'. This indicates a requirement for pharmaceutical products used in the treatment of cancer (oncology) and conditions involving the immune system (immunomodulators). Immunomodulators can be used to either stimulate or suppress the immune response, depending on the medical condition. The tender is likely issued by a public health authority, hospital, or a central procurement agency responsible for supplying medications. The scope covers a range of specialized drugs essential for treating complex diseases. Interested bidders are typically pharmaceutical manufacturers or their authorized distributors. The tender documents will detail the specific list of oncology and immunomodulator drugs required, including their active ingredients, dosages, forms (e.g., injectable, oral), quantities, packaging, and required quality standards (e.g., GMP certification). The evaluation criteria will focus on the ability to supply the full range of products, compliance with pharmaceutical regulations, delivery reliability, and cost-effectiveness. This procurement is critical for ensuring patient access to vital treatments within the public healthcare system.

This is a supplies contract in the health and medical services, trade and industry and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 64,383.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.